Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.69% |
| 2 | Industrials | 9.96% |
| 3 | Consumer Discretionary | 8.03% |
| 4 | Healthcare | 7.46% |
| 5 | Financials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Main Street Capital
MAIN
$5.45B
| $6.91M | 0.01% |
133,125
+13,118
| +11% | +$691K |
|
1177
Qiagen
QGEN
$9.1B
| $6.9M | 0.01% |
176,542
-257,050
| -59% | -$9.55M |
|
1178
PUT
Northern Oil and Gas
NOG
$2.91B
| $6.9M | 0.01% |
380,000
| – | – |
|
1179
Ryanair
RYAAY
$28.9B
| $6.84M | 0.01% |
105,669
-151,414
| -59% | -$8.93M |
|
|
PVLA
1180
Palvella Therapeutics
PVLA
$2.05B
| $6.81M | 0.01% |
44,536
-52,190
| -54% | -$6.33M |
|
1181
Silgan Holdings
SLGN
$4.48B
| $6.79M | 0.01% |
+146,322
| New | +$5.85M |
|
1182
PUT
Organon & Co
OGN
$3.61B
| $6.77M | 0.01% |
+500,000
| New | +$5.98M |
|
|
WSR
1183
DELISTED
Whitestone REIT
WSR
| $6.74M | 0.01% |
+355,674
| New | +$6.68M |
|
1184
Centuri Holdings
CTRI
$2.16B
| $6.74M | 0.01% |
+222,729
| New | +$7.19M |
|
1185
PUT
Iris Energy
IREN
$15B
| $6.73M | 0.01% |
147,200
-255,900
| -63% | -$13.3M |
|
|
SLN
1186
Silence Therapeutics
SLN
$825M
| $6.71M | 0.01% |
+610,980
| New | +$4.3M |
|
1187
LXP Industrial Trust
LXP
$3.59B
| $6.69M | 0.01% |
124,088
-240,615
| -66% | -$12.4M |
|
1188
Energizer
ENR
$1.47B
| $6.67M | 0.01% |
311,162
-285,042
| -48% | -$5.43M |
|
1189
CALL
Deere & Co
DE
$175B
| $6.66M | 0.01% |
10,500
-11,300
| -52% | -$6.55M |
|
1190
PUT
Bristol-Myers Squibb
BMY
$137B
| $6.64M | 0.01% |
115,200
-349,400
| -75% | -$20.1M |
|
1191
Old National Bancorp
ONB
$9.87B
| $6.63M | 0.01% |
255,983
-1,772,053
| -87% | -$42.6M |
|
1192
CALL
Choice Hotels
CHH
$4.93B
| $6.62M | 0.01% |
+60,000
| New | +$6.64M |
|
1193
Ball Corp
BALL
$16.8B
| $6.61M | 0.01% |
105,864
-596,924
| -85% | -$35.1M |
|
1194
Newell Brands
NWL
$2.59B
| $6.6M | 0.01% |
1,075,147
-1,616,545
| -60% | -$6.83M |
|
1195
Genius Sports
GENI
$2.16B
| $6.6M | 0.01% |
1,089,209
-848,155
| -44% | -$4.39M |
|
1196
Winmark
WINA
$1.24B
| $6.6M | 0.01% |
15,598
+14,938
| +2,263% | +$5.84M |
|
1197
BGC Group
BGC
$5.63B
| $6.59M | 0.01% |
616,826
+465,405
| +307% | +$5.21M |
|
1198
SITE Centers
SITC
$161M
| $6.58M | 0.01% |
1,658,021
-2,648
| -0.2% | -$13.8K |
|
1199
CALL
Union Pacific
UNP
$183B
| $6.56M | 0.01% |
24,100
+21,700
| +904% | +$5.7M |
|
1200
CALL
Merck
MRK
$376B
| $6.55M | 0.01% |
51,000
+34,800
| +215% | +$4.07M |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.